Is There a TIME and Place for Thrombolytics in Malignant Pleural Effusions?
Am J Respir Crit Care Med
.
2018 Feb 15;197(4):422-423.
doi: 10.1164/rccm.201710-2044ED.
Authors
Frank Schembri
1
,
J Scott Ferguson
2
Affiliations
1
1 The Pulmonary Center Boston University School of Medicine Boston, Massachusetts and.
2
2 Division of Pulmonary and Critical Care University of Wisconsin School of Medicine and Public Health Madison, Wisconsin.
PMID:
29072846
DOI:
10.1164/rccm.201710-2044ED
No abstract available
Publication types
Editorial
Comment
MeSH terms
Fibrinolytic Agents
Humans
Pleural Effusion*
Pleural Effusion, Malignant*
Urokinase-Type Plasminogen Activator
Substances
Fibrinolytic Agents
Urokinase-Type Plasminogen Activator